Načítá se...
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease
PURPOSE: Leiomyosarcoma (LMS) is a soft-tissue sarcoma characterized by multiple copy number alterations (CNAs) and without common recurrent single-nucleotide variants. We evaluated the feasibility of detecting circulating tumor DNA (ctDNA) with next-generation sequencing in a cohort of patients wit...
Uloženo v:
Vydáno v: | JCO Precis Oncol |
---|---|
Hlavní autoři: | , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
American Society of Clinical Oncology
2019
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380497/ https://ncbi.nlm.nih.gov/pubmed/30793095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00235 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|